See the published version of this preprint at Trials.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
SeyedBahman Panahande
Yasuj University of Medical Sciences
Corresponding Author
ORCiD: https://orcid.org/0000-0002-7008-2449
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Objectives
This study is conducted to investigate efficacy of pomegranate juice on inflammatory biomarkers, C-reactive protein (CRP), interleukin 6(IL-6), erythrocyte sedimentation rate (ESR) and complete blood count (CBC) in hospitalized patients with mild to moderate coronavirus disease 2019 (COVID- 19).
Trial Design
This is a randomized, placebo-controlled, double-blind, parallel 2-arm (1:1 ratio) clinical trial.
Keywords
COVID-19, Randomized Controlled Trial, Protocol, Pomegranate Juice, CRP, IL-6, CBC, ESR
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Trials.
Version 1
Posted 18 Mar, 2021
No community comments so far
Editorial decision: Accept
On 15 Mar, 2021
Reviewers invited
Invitations sent on 14 Mar, 2021
Reviews received
Received 14 Mar, 2021
Editor invited
On 14 Mar, 2021
First submitted
On 06 Mar, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
See the published version of this preprint at Trials.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
SeyedBahman Panahande
Yasuj University of Medical Sciences
Corresponding Author
ORCiD: https://orcid.org/0000-0002-7008-2449
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Trials.
Version 1
Posted 18 Mar, 2021
No community comments so far
Editorial decision: Accept
On 15 Mar, 2021
Reviewers invited
Invitations sent on 14 Mar, 2021
Reviews received
Received 14 Mar, 2021
Editor invited
On 14 Mar, 2021
First submitted
On 06 Mar, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Trials.
Objectives
This study is conducted to investigate efficacy of pomegranate juice on inflammatory biomarkers, C-reactive protein (CRP), interleukin 6(IL-6), erythrocyte sedimentation rate (ESR) and complete blood count (CBC) in hospitalized patients with mild to moderate coronavirus disease 2019 (COVID- 19).
Trial Design
This is a randomized, placebo-controlled, double-blind, parallel 2-arm (1:1 ratio) clinical trial.
Loading...